Cytokinetics, Inc. (CYTK)
61.70
-1.25
(-1.99%)
USD |
NASDAQ |
Mar 20, 16:00
61.69
-0.01
(-0.02%)
After-Hours: 20:00
Cytokinetics EPS Diluted (Quarterly) : -1.495 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| Lifecore Biomedical, Inc. | -0.2458 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Insmed, Inc. | -1.538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -183.03M |
| Revenue (Quarterly) | 17.76M |
| Total Expenses (Quarterly) | 200.79M |
| Enterprise Value | 7.998B |
| Gross Profit Margin (Quarterly) | 83.89% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -10.59% |
| Normalized Earnings Yield | -9.478 |